PT - JOURNAL ARTICLE AU - Tian, Suyan AU - Zhu, Xuetong AU - Sun, Xuejuan AU - Wang, Jinmei AU - Zhou, Qi AU - Wang, Chi AU - Chen, Li AU - Xu, Jiancheng TI - Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19 AID - 10.1101/2020.04.04.20053280 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.04.20053280 4099 - http://medrxiv.org/content/early/2020/04/07/2020.04.04.20053280.short 4100 - http://medrxiv.org/content/early/2020/04/07/2020.04.04.20053280.full AB - Objective To explore longitudinal change patterns of key laboratory tests in patients with COVID-19, and to identify independent prognostic factors by examining the associations between laboratory findings and outcomes of patients.Methods The multicenter study prospectively included 59 patients with COVID-19 treated at Jilin province from January 21, 2020 to May 5, 2020. Laboratory tests were included haematological, biochemical, and immunological tests.Results Laboratory findings, the characteristics of epidemiological and demographic data were extracted from electronic medical records. Eosinopenia was shown in 52.6% cases at onset, and the average value of eosinophil continued to significantly increase thereafter. Lymphopenia was found in 40.4% cases at onset, and the average value of lymphocyte was slowly elevated after day 5. Thrombocytopenia was shown in 12.3% cases at onset, and the average value of mean platelet volume was decreased sharply after day 7. The values of aspartate aminotransferase, lactate dehydrogenase, creatine kinase, creatinine kinase-muscle/brain activity, and cardiac troponin I, serum cardiac markers, were beyond the upper limit of RI from 6.1% to 30.6% at onset. The abnormity of liver function tests, kidney function tests, electrolytes was 2.0%∼59.2%, 2.0%∼4.1%, 6.0%∼30.0%, respectively. Eosinophil, platelet and carbondioxide combining power were selected as the prognostic factors.Conclusions The haematological, biochemical, and immunological tests were found significant abnormity at onset and longitudinal change patterns in the patients with COVID-19. Age, Eosinophil, PLT and CO2 may used to predict the recovery probability. Risk stratification and management could be improved for the patients with COVID-19 according to temporal trajectories of laboratory tests.Article Summary The longitudinal change patterns of the laboratory characteristics of affected patients were important to identify prognosis. Eosinophil, platelet and carbondioxide combining power may be independent predictors of recovery in patients with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from Jilin Science and Technology Development Program (no.20170623092TC-09, to Dr. Jiancheng Xu; no.20190304110YY to Dr. Jiancheng Xu), The First Hospital Translational Funding for Scientific &Technological Achievements (no. JDYYZH-1902002 to Dr. Jiancheng Xu).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw data required to reproduce these findings cannot be shared at this time as the data also forms part of an ongoing study.